35 results on '"Ogale, Sarika"'
Search Results
2. Real-world patterns of biomarker testing and targeted therapy in de novo metastatic non-small cell lung cancer patients in the US oncology network
3. Clinical Value of Timely Targeted Therapy for Patients With Advanced Non–Small Cell Lung Cancer With Actionable Driver Oncogenes
4. Work disability, lost productivity and associated risk factors in patients diagnosed with systemic lupus erythematosus.
5. Cost–effectiveness of Adjuvant Atezolizumab for Patients with Stage II–IIIA PD-L1+ Non-Small-Cell Lung Cancer
6. Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database
7. Real-world adjuvant chemotherapy patterns and outcomes among elderly patients with resected early non-small-cell lung cancer in the USA
8. Economic Evaluation of Tocilizumab Monotherapy Compared to Adalimumab Monotherapy in the Treatment of Severe Active Rheumatoid Arthritis
9. Estimating recurrences prevented and costs avoided with atezolizumab in early non‐small cell lung cancer in the United States
10. Use of Anti-Tumor Necrosis Factor Therapy: A Retrospective Study of Monotherapy and Adherence to Combination Therapy with Non-Biologic Disease-Modifying Anti-Rheumatic Drugs
11. Estimating recurrences prevented and costs avoided with atezolizumab in early non‐small cell lung cancer in the United States.
12. Assessing Methotrexate Adherence in Rheumatoid Arthritis: A Cross-Sectional Survey
13. Comparison of Biologic Disease-Modifying Antirheumatic Drug Therapy Persistence Between Biologics Among Rheumatoid Arthritis Patients Switching from Another Biologic
14. Comparison of Healthcare Costs Between Rheumatoid Arthritis Patients Treated with Infused Biologics After Switching from Another Biologic
15. Real-world adherence and persistence with anaplastic lymphoma kinase inhibitors in non–small cell lung cancer
16. Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis
17. A RESPONSE TO “THE POTENTIAL LONG-TERM COMPARATIVE EFFECTIVENESS OF LAROTRECTINIB AND ENTRECTINIB FOR SECOND-LINE TREATMENT OF TRK FUSION-POSITIVE METASTATIC LUNG CANCER”
18. Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study
19. Additional file 1: of Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database
20. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma
21. Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer
22. Patterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort study
23. Primary Sjögren's Syndrome: health experiences and predictors of health quality among patients in the United States
24. Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experiment
25. Differences in Patients with Progressive Versus Non-Progressive AML, CLL, or NHL: Implications for Proposed Bundled Payment Strategies
26. Comparison of Biologic Disease-Modifying Antirheumatic Drug Therapy Persistence Between Biologics Among Rheumatoid Arthritis Patients Switching from Another Biologic
27. Survival and Lifetime Costs Associated With First-Line Bevacizumab Use in Older Patients With Metastatic Colorectal Cancer
28. Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs – a systematic review and network meta-analysis
29. Incidence of Hepatic Resection Among Colorectal Cancer Patients with Liver Metastases
30. Extending Targeted Therapy Beyond First-Line (1L) Chemotherapy Backbone: Real-World Treatment Patterns and Outcomes in Patients with Metastatic Colorectal Cancer (MCRC)
31. Patterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort study
32. Effect of rituximab on physical function and quality of life in patients with rheumatoid arthritis previously untreated with methotrexate
33. Primary Sjögren's Syndrome: health experiences and predictors of health quality among patients in the United States
34. Cost-effectiveness of large-panel next-generation sequencing in guiding first-line treatment decisions for patients with nonsquamous advanced non-small cell lung cancer.
35. Claims identification of patients with severe cancer-related symptoms.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.